Are Allergy Shots Covered by Insurance? A Payer-by-Payer Map

No prior authorization is required for standard in-office allergy shots at most major commercial insurers — UnitedHealthcare, Blue Cross Blue Shield, Aetna, and Cigna all cover SCIT without prior auth when standard medical-necessity criteria are met. This is one of the more patient-friendly aspects of allergy shot coverage compared to biologics like omalizumab (Xolair), which require prior authorization at all major payers. However, venom immunotherapy for stinging-insect allergies may require documentation of an anaphylactic episode at some plans. FDA-approved sublingual immunotherapy tablets (Grastek, Ragwitek, Odactra, Oralair) do require prior authorization at all major commercial insurers, which distinguishes them from SCIT.

Yes, Medicare Part B covers allergy shots under the Physician Fee Schedule with 20% beneficiary coinsurance after the $257 annual deductible (2025). Coverage applies to standard in-office allergen immunotherapy codes — CPT 95115, 95117, 95165 — and to allergy testing (CPT 95004, 95024). Specific IgE blood testing (CPT 86003) is covered under the Clinical Laboratory Fee Schedule with no patient coinsurance. Medicare does NOT cover sublingual immunotherapy in any form under National Coverage Determination 110.9. Medicare Advantage (Part C) plans must cover the same SCIT services as Part B but typically convert the 20% coinsurance into fixed copays of $0-$50 per visit, and may impose prior authorization for specialist visits.

California Medi-Cal explicitly lists antigen preparation (CPT 95165 and related codes 95120-95164) as a non-benefit in the Medi-Cal Allergy Manual — meaning the state will not pay for the allergen extract itself, only for the injection administration. This is widely considered the largest single Medicaid coverage gap for allergy shots nationally. Because extract preparation is the dominant cost driver (roughly $293-$600 per year at Medicare and commercial rates), this exclusion effectively makes SCIT financially impractical for most Medi-Cal providers to offer. Texas Medicaid covers allergy shots with prior authorization, New York Medicaid covers standard codes, and Florida Medicaid covers medically necessary immunotherapy — but coverage conditions vary by managed care organization within each state.

Yes, allergy shots qualify as eligible medical expenses for Health Savings Accounts (HSA), Flexible Spending Accounts (FSA), and Health Reimbursement Arrangements (HRA) under IRS Publication 502 and the CARES Act of 2020. This applies to all components of allergy shot treatment — initial allergy testing, allergen extract preparation, injection administration fees, and specialist office visit copays. Using pre-tax HSA or FSA dollars effectively reduces your net out-of-pocket by your marginal tax rate — typically 22-37% for most working adults. FDA-approved SLIT tablets are also eligible as prescription drug expenses. Patients planning to start allergy shots who have access to an HSA can maximize contributions before treatment begins to reduce the first-year workup cost.

Hospital-owned outpatient departments (HOPDs) charge a facility fee on top of the physician professional fee for every allergy shot visit. This facility fee — typically $200-$1,500 or more per visit — is billed as a separate claim under hospital billing rules and is often subject to a separate hospital deductible. The professional fee alone (what a private allergist charges) is $25-$50 at Medicare rates; the facility fee at an academic medical center can exceed $2,000, as documented at University Hospitals Cleveland and M Health Fairview in Minnesota. Patients should confirm before starting treatment whether their allergist practices in a physician office setting or a hospital-owned clinic, as this single factor can multiply costs by 5-10 times even for fully insured patients.

Yes, commercial insurance covers allergy shots for children using the same CPT codes and medical-necessity criteria as for adults. The key medical-necessity threshold — documented IgE-mediated allergy, symptoms of allergic rhinitis or asthma, and inadequate response to avoidance and pharmacotherapy — applies to pediatric patients as well. Medicaid covers pediatric allergy shots in most states, and the EPSDT (Early and Periodic Screening, Diagnostic, and Treatment) mandate requires Medicaid to cover medically necessary services for patients under age 21, which may provide a coverage pathway in states with otherwise limited immunotherapy coverage. Families should confirm their child's specific health plan's pediatric allergy coverage and whether a referral from the child's pediatrician is required.

Insurance coverage for sublingual allergy drops depends on the specific product. FDA-approved SLIT tablets — Grastek (grass), Ragwitek (ragweed), Odactra (dust mite), and Oralair (5-grass) — are covered by most commercial insurers with prior authorization, and manufacturer patient assistance programs can reduce costs to $15-$35 per month. Compounded sublingual drops (multi-allergen mixtures prescribed by allergists and prepared by compounding pharmacies) are generally not covered by insurance because they are off-label, and no commercial insurer or government payer routinely covers them. Medicare Part B explicitly excludes all forms of SLIT under NCD 110.9. Patients considering sublingual drops should plan for out-of-pocket costs unless they qualify for FDA-approved tablets for a single-allergen indication.